Cathie Wood (ARK Invest) bought GENB via ARKG
ARK's ARKG bought 63,768 shares of Generate Biomedicines Inc (GENB), representing 0.0671% of ETF, according to ARK's official daily trade file.
Signal
Investor Move
Action
Buy
Capital
$1.1M disclosed value
Why it matters
ARK publishes this official daily trade disclosure after execution, giving a more current view than quarterly 13F filings.